BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 15990749)

  • 1. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Flaker GC; Belew K; Beckman K; Vidaillet H; Kron J; Safford R; Mickel M; Barrell P;
    Am Heart J; 2005 Apr; 149(4):657-63. PubMed ID: 15990749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of management patterns and clinical outcomes in patients with atrial fibrillation in Canada and the United States (from the analysis of the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] database).
    O'Hara GE; Charbonneau L; Chandler M; Vidaillet HJ; Philippon F; Sami M; Rocco TA; Padder FA; Champagne J; Pratt CM; Coutu B; Wyse DG;
    Am J Cardiol; 2005 Sep; 96(6):815-21. PubMed ID: 16169368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL; Safford RE; ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary surgery in patients with preexisting chronic atrial fibrillation: early and midterm clinical outcome.
    Rogers CA; Angelini GD; Culliford LA; Capoun R; Ascione R
    Ann Thorac Surg; 2006 May; 81(5):1676-82. PubMed ID: 16631655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).
    Cooper HA; Bloomfield DA; Bush DE; Katcher MS; Rawlins M; Sacco JD; Chandler M;
    Am J Cardiol; 2004 May; 93(10):1247-53. PubMed ID: 15135698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Jenkins LS; Brodsky M; Schron E; Chung M; Rocco T; Lader E; Constantine M; Sheppard R; Holmes D; Mateski D; Floden L; Prasun M; Greene HL; Shemanski L
    Am Heart J; 2005 Jan; 149(1):112-20. PubMed ID: 15660042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery?
    Ngaage DL; Schaff HV; Barnes SA; Sundt TM; Mullany CJ; Dearani JA; Daly RC; Orszulak TA
    Ann Thorac Surg; 2006 Oct; 82(4):1392-9. PubMed ID: 16996940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
    Rienstra M; Van Gelder IC; Hagens VE; Veeger NJ; Van Veldhuisen DJ; Crijns HJ
    Eur Heart J; 2006 Feb; 27(3):357-64. PubMed ID: 16275661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
    Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators.
    Am J Cardiol; 1997 May; 79(9):1198-202. PubMed ID: 9164885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
    Dagres N; Nieuwlaat R; Vardas PE; Andresen D; Lévy S; Cobbe S; Kremastinos DT; Breithardt G; Cokkinos DV; Crijns HJ
    J Am Coll Cardiol; 2007 Feb; 49(5):572-7. PubMed ID: 17276181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
    To AC; Yehia M; Collins JF
    Nephrology (Carlton); 2007 Oct; 12(5):441-7. PubMed ID: 17803466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.
    Chung MK; Shemanski L; Sherman DG; Greene HL; Hogan DB; Kellen JC; Kim SG; Martin LW; Rosenberg Y; Wyse DG;
    J Am Coll Cardiol; 2005 Nov; 46(10):1891-9. PubMed ID: 16286177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study.
    Curtis AB; Seals AA; Safford RE; Slater W; Tullo NG; Vidaillet H; Wilber DJ; Slee A
    Am Heart J; 2005 Feb; 149(2):304-8. PubMed ID: 15846269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.